Announcing Results from Verge Genomics Proof-of-Concept ALS Clinical Trial

awards

Modality Wins Distinguished Poster Award at ISCTM

February 2024

At the 20th International Society for CNS Clinical Trials and Methodology (ISCTM), Modality Senior Research Scientist, Hardik Kothare, presented "Relationship Between Sample Size and Responsiveness of Speech-Based Digital Biomarkers in ALS". Congratulations to Hardik and coauthors Michael Neumann and Vikram Ramanarayanan!

. . .

Modality Research Scientist wins ISCTM New Investigator Award

December 2023

In 2012 the International Society for CNS Clinical Trials and Methodology (ISCTM) created a program to recognize promising new investigators across the broad range of methodological, regulatory and substantive programmatic interests of the society. Up to five “New Investigator Award” applicants are selected each year.

We are very pleased to share that Modality Research Scientist, Hardik Kothare, PhD, will be recognized as a New Investigator awardee during the opening of ISCTM’s 20th Annual Scientific Meeting in February 2024. He will be presenting a poster on the relationship between sample size and responsiveness of speech-based digital biomarkers in ALS.

Congratulations Dr. Kothare!

. . .

Winner of the 2023 ASHA Meritorious Poster award

November 2023

Modality.AI's Lyme Disease poster has been awarded a “Meritorious Poster” award and honored as part of ASHA’s “Changemaker" Session.

. . .

Winner of the 2022 MedCity INVEST Pitch Perfect Contest

April 22, 2022

Modality.AI's CEO, David Suendermann-Oeft, is the 2022 Winner of the MedCity INVEST Pharma Tech Pitch Contest

. . .

Healthtech Startup Award Winner

March 29, 2021

HealthTech Networking Club member and winner of the HealthTech Startup Award in January, David Suendermann-Oeft, CEO and Founder of Modality.AI, spoke with the bene : studio team about what inspired him to start the company, their biggest achievements so far, and advice for startup leaders in the digital health space.

. . .

Modality.AI awarded Second Place in the RESI Investor's Pitch Challenge

March 18, 2021

Modality.AI presented at Life Science Nation's Innovator's Pitch Challenge during the Redefining Early Stage Investments (RESI) Conference in March, 2021. Modality.AI was awarded Second Place.

We are thrilled that the RESI community thinks so highly of our groundbreaking technology and accomplishments. Thank you for the opportunity to present at the event. We look forward to future RESI and LSciNation conferences.